InVivoPlus polyclonal Armenian hamster IgG

Ariyan CE, Brady MS, Siegelbaum RH, et al. Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade. Cancer Immunol Res. 2018,6(2):189-200. doi: 10.1158/2326-6066.CIR-17-0356

Awe O, Hufford MM, Wu H, et al. PU.1 Expression in T Follicular Helper Cells Limits CD40L-Dependent Germinal Center B Cell Development. J Immunol. 2015,195(8):3705-15. doi: 10.4049/jimmunol.1500780

Imai Y, Ayithan N, Wu X, et al. Cutting Edge: PD-1 Regulates Imiquimod-Induced Psoriasiform Dermatitis through Inhibition of IL-17A Expression by Innate γδ-Low T Cells. J Immunol. 2015,195(2):421-5. doi: 10.4049/jimmunol.1500448

Li C, Li W, Xiao J, et al. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. EMBO Mol Med. 2015,7(6):754-69. doi: 10.15252/emmm.201404578

Van der Jeught K, Joe PT, Bialkowski L, et al. Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity. Oncotarget. 2014,5(20):10100-13.

Gopinath S, Lichtman JS, Bouley DM, et al. Role of disease-associated tolerance in infectious superspreaders. Proc Natl Acad Sci U S A. 2014,111(44):15780-5. doi: 10.1073/pnas.1409968111

Khmaladze Ia, Kelkka T, Guerard S, et al. Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice. Proc Natl Acad Sci U S A. 2014,111(35):E3669-78. doi: 10.1073/pnas.1405798111

Ballesteros-Tato A, León B, Lee BO, et al. Epitope-specific regulation of memory programming by differential duration of antigen presentation to influenza-specific CD8(+) T cells. Immunity. 2014,41(1):127-40. doi: 10.1016/j.immuni.2014.06.007

Özdemir BC, Pentcheva-Hoang T, Carstens JL, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014,25(6):719-34. doi: 10.1016/j.ccr.2014.04.005

Church SE, Jensen SM, Antony PA, et al. Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells. Eur J Immunol. 2014,44(1):69-79. doi: 10.1002/eji.201343718